Isala Klinieken Stichting

At Isala Klinieken Stichting in Zwolle, a large share of research focuses on cancer and blood disorders, including studies in lung cancer, breast cancer, colorectal cancer, pancreatic cancer, urothelial cancer, and leukemia. These trials are designed to test new treatments, compare treatment strategies, and improve outcomes for patients with advanced or hard-to-treat disease.

• Non-small cell lung cancer, small-cell lung cancer, and metastatic lung cancer studies exploring better survival and disease control
• Multiple myeloma, acute myeloid leukemia, chronic lymphocytic leukemia, and lymphoma research aimed at improving response and long-term control
• Breast cancer, bladder cancer, renal cell carcinoma, and melanoma trials evaluating newer anti-cancer therapies
• Pancreatic cancer and colorectal cancer studies focused on treatment effectiveness and surgical outcomes

Many of these studies examine whether new combinations or targeted approaches can improve survival, reduce recurrence, or offer more effective care for patients with advanced solid tumors and hematologic malignancies.

The site also conducts substantial research in cardiovascular disease and vascular medicine, with trials involving acute coronary syndromes, heart failure, atrial fibrillation, stroke, and peripheral arterial disease. The main goal is to improve prevention, emergency care, and long-term outcomes for people at high risk of heart and blood vessel complications.

• Acute coronary syndrome and myocardial infarction research evaluating safer and more effective treatment approaches
• Stroke and intracerebral hemorrhage studies aimed at limiting brain injury and improving recovery
• Heart failure, atrial fibrillation, and high cardiovascular risk trials focused on prevention and risk reduction
• Peripheral arterial disease and atherosclerotic disease research addressing circulation problems and vascular outcomes

These studies reflect a strong interest in testing new therapies and refining care for cardiovascular disease across both urgent and preventive settings.

Respiratory research at Isala Klinieken Stichting includes work on COPD, asthma, chronic cough, and other lung diseases. The trials are aimed at improving symptom control, reducing flare-ups, and identifying better treatment options for patients with persistent breathing problems.

• Chronic obstructive pulmonary disease studies assessing ways to reduce exacerbations and improve daily function
• Severe asthma research focused on patients with eosinophilic disease and unmet treatment needs
• Refractory chronic cough trials exploring new ways to relieve ongoing symptoms
• Small-cell lung cancer and other thoracic oncology studies with a respiratory focus

This area combines pulmonology and oncology, with a clear emphasis on better symptom management and improved treatment effectiveness.

Another major research theme involves gastrointestinal diseases, especially pancreatic cancer, rectal cancer, colorectal cancer, and related digestive conditions. The studies examine how to improve surgery, systemic treatment, and overall outcomes in both early and advanced disease.

• Pancreatic cancer and borderline resectable disease trials evaluating better treatment strategies before surgery
• Rectal cancer studies focused on disease control, surgical success, and preservation of function
• Colorectal cancer and colorectal liver metastases research testing ways to extend survival
• Digestive system diseases and intestinal malabsorption studies addressing supportive and pediatric care

Research in this field often aims to improve treatment effectiveness, support surgical decision-making, and enhance quality of life for patients with complex digestive cancers.

Clinical trials in neurology at the Zwolle site include studies in stroke, migraine, multiple sclerosis, and intracerebral hemorrhage. The purpose is to improve acute care, reduce neurological damage, and support better long-term function for patients with brain and nerve disorders.

• Ischemic stroke and transient ischemic attack research focused on recovery after acute events
• Intracerebral hemorrhage studies examining ways to reduce secondary brain injury
• Migraine trials, including work in younger patients, aimed at symptom relief and safety
• Multiple sclerosis research addressing chronic neurological disease management

These studies combine diagnostic and therapeutic research to support faster intervention and improved neurological outcomes.

A strong hematology program supports research in multiple myeloma, lymphoma, acute leukemia, and other blood cancers. The trials are generally aimed at improving remission rates, preventing relapse, and finding better maintenance or combination treatment approaches.

• Multiple myeloma studies examining treatment response and maintenance strategies
• Diffuse large B-cell lymphoma, mantle cell lymphoma, and non-Hodgkin lymphoma trials testing more effective cancer control
• Acute myeloid leukemia and myelodysplastic syndrome research focused on newly diagnosed and difficult-to-treat patients
• Chronic lymphocytic leukemia and small lymphocytic lymphoma studies exploring long-term disease management

Much of this work centers on targeted therapy, maintenance treatment, and improving outcomes for patients who may not respond well to standard care.

Research in metabolic disease, endocrinology, and kidney disease includes studies on obesity, type 2 diabetes, hypertension, chronic kidney disease, and acute kidney injury. These trials aim to improve prevention, protect organ function, and support better long-term health.

• Obesity and overweight studies evaluating cardiovascular and kidney-related benefits
• Type 2 diabetes and statin intolerance research focused on risk reduction and treatment adherence
• Chronic kidney disease and acute kidney injury trials addressing prevention and organ protection
• Hormonal disorders, including primary aldosteronism, studied for improved diagnosis and management

This research combines prevention, diagnostics, and treatment optimization to address common chronic conditions seen in everyday practice.

The site’s analytical, diagnostic, and surgical research portfolio includes studies designed to improve how diseases are detected and treated around the time of surgery. These trials often focus on making procedures safer, more precise, and more effective for patients.

• Surgical procedures research aimed at improving operative precision and outcomes
• Urinary tract imaging and ureter visualization studies supporting better intraoperative guidance
• Diagnostic techniques and investigative methods used to refine patient assessment
• Anesthesia and analgesia studies addressing comfort and perioperative care

These projects show a practical interest in improving both diagnosis and therapeutic procedures across a range of hospital-based specialties.

Additional trials at Isala Klinieken Stichting address infectious diseases, immune system disorders, and inflammatory conditions. The research aims to improve control of infection, reduce complications, and test new ways to manage chronic immune-mediated illness.

• Bacterial infections and sepsis studies focused on serious hospital-treated illness
• Immune system diseases and rheumatic disease research evaluating better disease control
• Inflammatory bowel disease and Crohn’s disease trials exploring improved symptom management
• Pulmonary sarcoidosis and other immune-mediated disorders studied for more effective care

This work reflects a broad commitment to immunology and infectious disease research that can benefit both acute and chronic patient care.